About China Venture Capital
China Venture Capital is a venture capital firm founded in 2000. It is primarily based out of Beijing, China. As of May 2026, China Venture Capital is an active investor, having invested in 164 companies, with 3 new investments in the last 12 months. It primarily invests in Series A round in China based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Series A round of Zhongke Diwuji Overall, China Venture Capital portfolio has seen 2 unicorns and 7 IPOs including key companies like Liepin, Farasis Energy and Jusfoun Big Data. A lot of funds co-invest with China Venture Capital, with names like Industrial Bank sharing a substantial percentage of its portfolio. China Venture Capital has team of 11 people including 7 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 5 more
Portfolio IPOs
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months
China Venture Capital's List of Top Investments
China Venture Capital has a portfolio of 164 companies, including 2 unicorns. Their most notable investments are in Zhejiang Konghui Automobile Technology and Imbioray.Their portfolio spans across and China. They have invested in Life Sciences, Enterprise Applications, HealthTech and 27 other sectors, across stages such as Series A, Seed and 5 more. Here is the list of top investments by China Venture Capital:1. Liepin
Provider of job board platform for the multi industry. It allows businesses to post job positions, download resumes, and advertise openings, and it also allows job seekers to send resumes and acquire contact information of businesses and headhunters. The website has job postings for a variety of sectors and jobs, such as engineering, construction, manufacturing, retail, research and development, and more. It also provides college recruiting and corporate recruitment services.
Key facts about Liepin
- Founded Year: 2004
- Location: Beijing (China)
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $170M
- Employee Count: 96 as on Aug 31, 2026
- Investors: Ledger Capital, SDIC Innovation and 7 Others
- Latest Funding Round: Series D, Jun 28, 2016, $*****
- Highlight: Editors' Pick
Manufacturer of lithium-ion batteries for electric vehicles and energy storage. The company provides battery products for green transportation, smart energy storage, low-carbon construction, and portable power applications. It focuses on developing and producing batteries for various applications. The company has received recognition for its battery products.
Key facts about Farasis Energy
- Founded Year: 2002
- Location: Nanchang (China)
- Stage: Public
- Total Funding till date: $793M
- Employee Count: 205 as on Mar 31, 2026
- Investors: CDG Capital, Mercedes-Benz and 15 Others
- Latest Funding Round: Series C, Jul 03, 2020, $*****
- Highlight: Public
Provider of materials for OLED-Displays. It offers fine metal masks that help in the development of AMOLED-Screens by evaporating organic light-emitting materials. It has applications in consumer electronic items, including mobile phones, tablets, and wearable devices.
Key facts about Zhejiang Zhongling Technology
- Founded Year: 2020
- Location: Jiaxing (China)
- Stage: Series C
- Total Funding till date: $86.7M
- Investors: CMB International Capital, China Jianyin Investment and 13 Others
- Latest Funding Round: Series C, Nov 05, 2025, $*****
- Highlight: Editors' Pick
4. 91JinRong
91Jinrong provides a comparison platform for consumer loans and business loans. It enables borrowers to compare offers provided by multiple lenders. It also provides money management system to financial institutions.
Key facts about 91JinRong
- Founded Year: 2011
- Location: Beijing (China)
- Stage: Series C
- Total Funding till date: $42.3M
- Employee Count: 48 as on Aug 31, 2026
- Investors: Lightspeed Venture Partners, CBC Capital and 5 Others
- Latest Funding Round: Series C, Oct 19, 2016, $*****
- Highlight: Editors' Pick
Ningbo Menovo Pharmaceuticals Group is a manufacturer of APIs, intermediates and formulations. Their products cater mainly to therapeutic areas such as psychotropic, cardiovascular, antithrombotic, antitumor, gastrointestinal, anti-infection and veterinary applications. They market their products in Asia, Europe, Africa, South America and North America. The company also claims to offer a range of services for generic and other pharmaceutical companies. The company has manufacturing facilities with each of them specializing in tablet manufacturing, complex drug synthesis, and chiral technology and APIs and intermediates.
Key facts about Ningbo Menovo Pharmaceuticals
- Founded Year: 2004
- Location: Ningbo (China)
- Stage: Funding Raised
- Employee Count: 44 as on Sep 30, 2026
- Investors: BGI Co-win, China Venture Capital and 1 Other
China Venture Capital's Year-on-Year Investment Trends
China Venture Capital has invested in 164 companies over the last 18 years, with an average of 2 new investments annually in the last 10 years. In 2025, it made 1 investment, while as of May 2026, it has made 2 investments in this year. Its most recent first time investment was in Zhongke Diwuji.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 2 | 0 | 2 |
2025 | 1 | 0 | 1 |
2024 | 0 | 0 | 0 |
2023 | 2 | 0 | 2 |
2022 | 4 | 0 | 4 |
2021 | 4 | 0 | 4 |
2020 | 3 | 0 | 3 |
2019 | 0 | 0 | 0 |
2018 | 3 | 0 | 3 |
2017 | 2 | 0 | 2 |
China Venture Capital's Investments by Stage
China Venture Capital has made 15 investments in Series A stage with an average round size of $31M, 5 investments in Seed stage with an average round size of $2.28M and 4 investments in Series C stage with an average round size of $549M.Stage of entry | No. of Investments |
|---|---|
Series A | 15 |
Seed | 5 |
Series C | 4 |
Series B | 3 |
Angel | 1 |
Others | 2 |
Note: We have considered here, only first round of investments
China Venture Capital's Investments by Sector
China Venture Capital has a diverse portfolio, with companies operating in the High Tech, Enterprise Applications, Consumer, Life Sciences and EdTech. Notably, it has invested in 71 Enterprise (B2B) companies, 50 Tech companies, 24 Consumer (B2C) companies and at least 21 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
High Tech | 6 |
Enterprise Applications | 5 |
Consumer | 4 |
Life Sciences | 4 |
EdTech | 3 |
Others | 36 |
Note: We have considered here, only first round of investments
China Venture Capital's Investments by Geography
China Venture Capital has made most investments in China (27).China Venture Capital's recent investments
China Venture Capital has made 2 investments in 2026 so far - Zhongke Diwuji and Zhongkefifthera.Here are the most recent investments by China Venture Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
May 27, 2026 | - | Series A | 7400 | ||
May 27, 2026 | - | Series A | 6607 | [+5] | |
Nov 05, 2025 | China | Series C | 4880 | ||
Dec 27, 2023 | China | Series E | 2864 | [+1] | |
Jul 10, 2023 | China | Series A | 6210 |
Unicorns in China Venture Capital's Portfolio
China Venture Capital has 2 unicorns in its portfolio - Jusfoun Big Data and Liepin. The most recent unicorn in their portfolio is Jusfoun Big Data. It became a unicorn in 2019, 7 years before China Venture Capital first invested in it.Here is a list of unicorns in China Venture Capital's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
41 | Big data platform for enterprises | 2010 | Beijing | Series C | snbanho | ||
67 | Provider of job board platform for the multi industry | 2004 | Beijing | Series D | knudv{m |
IPOs and Publicly Listed companies in China Venture Capital's Portfolio
7 of China Venture Capital's portfolio companies have become public. Guoke Tiancheng got listed on the Shenzhen Stock Exchange (SZSE), in Aug 2024 at marketcap of $280M and HeNan LiLiang Diamond got listed on the Shanghai Stock Exchange (SSE) at marketcap of $192M.Here are China Venture Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 21, 2024 | - | - | 7802 | |
Sep 24, 2021 | - | - | 6974 | |
Jul 17, 2020 | Feb 11, 2018 | Series C | 2843 | |
Apr 26, 2012 | - | - | 3971 | |
Jan 08, 2010 | - | - | 8305 |
Team profile of China Venture Capital
China Venture Capital has a team of 11 members including 7 Partners and 3 Principals located in China. China Venture Capital's team does not sit on the board of any company as of now.Here is a list of top team members in China Venture Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | - | - | - | |
Partner | - | - | - | |
Partner | - | - | - | |
Partner | - | - | - | |
Partner | - | - | - | |
Partner | - | - | - | |
Partner | Zhengzhou | - | - | |
Principal | - | - | - | |
Principal | Haidian | - | - | |
Principal | China | - | - |
Co-investors of China Venture Capital
Over the past 18 years, 125 investors have co-invested in China Venture Capital's portfolio companies. This includes funds and angels.
- Invested before China Venture Capital: Shenzhen Capital Group, SBIR and 28 others have invested in rounds before China Venture Capital. There are 2 companies where Shenzhen Capital Group has invested before China Venture Capital and 1 company where SBIR has invested before China Venture Capital.
- Top Co-investors of China Venture Capital: 65 investors entered a company along with China Venture Capital. These include investors like Industrial Bank (2 companies).
- Invested after China Venture Capital: A total of 30 investors have invested in China Venture Capital's portfolio after their investments. Top Investors include CMB International Capital (2 companies), Mercedes-Benz (1 company) and Vinh Hoan (1 company).
Recent News related to China Venture Capital
•
•
A potential investment fund has emerged in Yangzhou, with Chinese venture capital investing about 52.46 million yuanPencilNews•Aug 23, 2024•China Venture Capital
•
•
Meszhuowei Completed Series B Financingfromgeek.com•Apr 29, 2024•Road Capital, China Venture Capital
•
JJC TEC Completed the E Round Financing, AGF InvestedPR Newswire•Dec 27, 2023•Beijing JJJ Technology, SDIC, Starlight Capital, Asia Green Fund and 6 others
•
Equipment manufacturer "Horlist" completed hundreds of millions of yuan in Series B financing36Kr•Sep 05, 2023•Beijing Hollister Technology, China Venture Capital, Guotai Junan Securities, CEC Capital
•
Chinese biopharmaceutical firm Pyrotech Therapeutics bags $97m in Series A roundShareandstocks•Jul 11, 2023•SDIC, China Venture Capital
•
"Yanming Biology" announced the completion of 700 million yuan in Series A financing36Kr•Jul 10, 2023•SDIC, China Venture Capital, China Taiping Insurance Group, Frees Fund and 2 others
•
Hithium secures Series C funding, poised for further technologicalEqualOcean•Jul 05, 2023•Hithium, China Life Insurance, Financial Street Capital Operation Center, Goldstone Investment and 16 others
•
Orend completed hundreds of millions of yuan in round C financingFENQ•Dec 27, 2022•China Venture Capital, SMIC, Walden International, State Power Investment Group and 2 others
